An albumin-recruiting lipid nanoparticle formulation promotes lymphatic drainage while avoiding liver accumulation. In preclinical models of cancers and infectious diseases, mRNA vaccines prepared from this lipid nanoparticle platform elicit robust immune responses and achieve remarkable efficacy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Pateev, I. et al. Biodistribution of RNA vaccines and of their products: evidence from human and animal studies. Biomedicines 12, 59 (2023). A comprehensive review on the biodistribution of mRNA vaccines, highlighting the phenomenon of liver accumulation.
Efe, C. et al. Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 76, 1576–1586 (2022). This paper reports liver injury and immune-mediated hepatitis following SARS-CoV-2 vaccination.
Famta, P. et al. Albumin-hitchhiking: fostering the pharmacokinetics and anticancer therapeutics. J. Control. Rel. 353, 166–185 (2022). A review article on the characteristics of albumin transport.
Abdallah, M. et al. Lymphatic targeting by albumin-hitchhiking: applications and optimisation. J. Control. Rel. 327, 117–128 (2020). A review article on the influence of the albumin-hitchhiking strategy on drug release and lymphatic drainage.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Feng, Y. et al. Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation. Nat. Mater. https://doi.org/10.1038/s41563-025-02284-w (2025).
Rights and permissions
About this article
Cite this article
Albumin-coated lipid nanoparticles are effective delivery systems for mRNA vaccines. Nat. Mater. 24, 1692–1693 (2025). https://doi.org/10.1038/s41563-025-02285-9
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41563-025-02285-9